Next Article in Journal
Frequency of icaA and icaD Determinants and Biofilm Formation Among Coagulase-Negative Staphylococci Associated with Nasal Carriage in Neonatal Intensive Care Units
Previous Article in Journal
Use of a Clinical Decision Support System (CDSS) to Improve Antimicrobial Stewardship Efforts at a Single Academic Medical Center
 
 
GERMS is published by MDPI from Volume 15 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Influenza Redefined—Clinical and Epidemiological Insight

by
Oana Săndulescu
1,*,
Anca Drăgănescu
2 and
Daniela Pițigoi
1
1
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Carol Davila University of Medicine and Pharmacy, No. 1 Dr. Calistrat Grozovici street, 021105 Bucharest, Romania
2
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, No. 1 Dr. Calistrat Grozovici Street, 021105 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Submission received: 3 March 2019 / Revised: 3 April 2019 / Accepted: 3 May 2019 / Published: 3 June 2019
With this year’s influenza season officially over, it’s time to pause and reflect on lessons learned. Despite the availability of influenza vaccination, this infection continues to pose a significant burden and an important strain on the healthcare system each year.
Identifying patients with influenza based on their signs and symptoms is quite straight-forward in the clinic during the cold season, and with access to rapid molecular diagnostics, laboratory confirmation can be obtained within a few hours following the initial patient consult.
However, when it comes to epidemiological surveillance, a systematic approach needs to be consistently applied and it is here that case definitions have been a matter of debate. Definitions for influenza-like illness (ILI) and severe acute respiratory infection (SARI) combine clinical signs and symptoms that occur suddenly within a specified time-frame, being suggestive for acute respiratory illness.
Recent studies have discussed whether all the "classical” ILI criteria are indeed needed. While the European Centre for Disease Prevention and Control defines clinical influenza criteria as "at least one systemic symptom (among fever/feverishness, malaise, headache, myalgia) and at least one respiratory symptom (among cough, sore throat, shortness of breath)” [1], the World Health Organization (WHO) has simplified the case definitions in 2011 and 2014, to include only "fever ≥38°C (or history of fever) plus cough” [2], since these two criteria appear to yield the best balance of sensitivity and specificity, and can be assessed in all age groups. The definition of fever has also been subject to discussion, particularly for elderly patients, where the threshold could be set as low as 37.3°C to increase the case definition performance [3].
The time-frame for assessing ILI or SARI criteria, generally regarded as 7 days, was revised by WHO to 10 days [2], although not all epidemiological studies, including those performed at our facility, have yet incorporated this revision.
In conclusion, since any given definition comes with advantages and disadvantages, when it comes to epidemiological surveillance, consistency is key. Regardless of the definition used, it is essential to be consistent from season to season, in order to generate an accurate picture, based on information that can be compared from year to year, allowing trend analysis.

Author Contributions

All authors had equal contributions.

Funding

None to declare for this manuscript.

Conflicts of Interest

OS, AD and DP have been involved in influenza studies: GIHSN (Sanofi Pasteur and Foundation for Influenza Epidemiology) and DRIVE (EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking).

References

  1. Commission implementing decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. (OJ L 170, 6.7.2018, p. 24).
  2. Fitzner, J.; Qasmieh, S.; Mounts, A.W.; et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ 2018, 96, 122–128. [Google Scholar] [CrossRef] [PubMed]
  3. Falsey, A.R.; Baran, A.; Walsh, E.E. Should clinical case definitions of influenza in hospitalized older adults include fever? Influenza Other Respir Viruses 2015, 9, 23–29. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Săndulescu, O.; Drăgănescu, A.; Pițigoi, D. Influenza Redefined—Clinical and Epidemiological Insight. GERMS 2019, 9, 60. https://doi.org/10.18683/germs.2019.1158

AMA Style

Săndulescu O, Drăgănescu A, Pițigoi D. Influenza Redefined—Clinical and Epidemiological Insight. GERMS. 2019; 9(2):60. https://doi.org/10.18683/germs.2019.1158

Chicago/Turabian Style

Săndulescu, Oana, Anca Drăgănescu, and Daniela Pițigoi. 2019. "Influenza Redefined—Clinical and Epidemiological Insight" GERMS 9, no. 2: 60. https://doi.org/10.18683/germs.2019.1158

APA Style

Săndulescu, O., Drăgănescu, A., & Pițigoi, D. (2019). Influenza Redefined—Clinical and Epidemiological Insight. GERMS, 9(2), 60. https://doi.org/10.18683/germs.2019.1158

Article Metrics

Back to TopTop